Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • bluesquid
    Junior Member
    • Aug 2012
    • 3

    seeking pool-seq experimental design advice

    Hi,
    I am asking for thoughts and suggestions on a re-sequencing project examining pooled samples of individual mosquitoes which are highly susceptible to malaria vs resistant.

    Here is my general experimental design:

    Infect 500 genetically diverse mosquitoes with malaria (These mosquitoes are from a colony that was founded from 100 wild-caught mated females and have been kept in the lab at reasonable population size for 5 years).

    Take the phenotypic extremes from these 500 individuals:
    40 with very high infections,
    20 that have very low infections, and
    20 that didn't get infected at all.
    (Exclude the 420 mosquitoes that fall in the middle).

    Carry out DNA extractions on all 80 individual mosquitoes.
    PicoGreen estimates of DNA quantity so equimolar amounts can be pooled.

    That is where I am now. My goal is to identify alleles (SNPs) which have very different frequencies between the phenotypes (e.g., Highly susceptible vs Resistant)

    Here is what I am struggling with.

    I have limited resources so can only afford 1 lane (possibly 2 if it makes a huge difference) of HiSeq PE100.

    My gut instinct is that the best approach would be to divide my DNA preps so that I make 3 separate library pools per phenotype using DIFFERENT individuals resulting in 9 pools (each phenotype with 3 (sort of) biological replicates) as follows:

    HiPoolA=13 individuals
    HiPoolB=13 individuals
    HiPoolC=14 individuals

    LowPoolA=6 individuals
    LowPoolB=7 individuals
    LowPoolC=7 individuals

    ResistantPoolA=6 individuals
    ResistantPoolB=7 individuals
    ResistantPoolC=7 individuals

    Each of the 9 pools could then be sequenced to ~8x on a single lane (mosquito genome is ~220Mb).

    Alternatively, I could forget this "biological replicate" idea, and pool all individuals by phenotype and sequence each of the 3 pools to ~25x.

    HiPool=40 individuals
    LowPool=20 individuals
    ResistantPool=20 individuals


    Given the small sample sizes that I have, the low coverage I can achieve per phenotype, and the resampling issues (sequencing the same individual repeatedly just by chance, leading to skewed allele frequencies), which design is better? Or is there another option that I am not considering (sequencing each individual 1x is not feasible because of the high cost of indexing).

    I am grateful for any thoughts/suggestions.
    Thank you!
    Mara

Latest Articles

Collapse

  • mylaser
    Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by mylaser
    Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
    If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
    This guide explains everything you need to know about...
    Yesterday, 01:13 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-02-2026, 11:08 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Working...